Type 2 diabetes patients who are 18 years and older
Open-Label Trial Comparing the Effect of (weekly) LY3298176 Versus (daily) Insulin Degludec on Glycemic Control in Patients With Type 2 Diabetes
GPGH
Study Length: 59 Weeks
Target Age/Sex: 18 years and older, Male and Female
Participants will receive at no cost: study product, study materials and study-specific procedures
Link: ClinicalTrials.gov